Dental Soft Tissue Regeneration Market - Global Forecast to 2030
商品番号 : SMB-90058
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 227 |
| 図表数 | 257 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
歯科軟組織再生市場 – 製品タイプ（自家移植片、合成バイオマテリアル、コラーゲンベースメンブレン）、用途（インプラント、歯周病）、エンドユーザー（歯科医院、DSO、独立クリニック）、地域別 – 2030年までの世界予測
歯科軟組織再生市場は、2025年の3億8,000万米ドルから2030年には5億3,000万米ドルに拡大し、この期間に年平均成長率（CAGR）6.8%で成長すると予測されています。この市場は、歯周病の発症率上昇、口腔衛生への意識の高まり、審美歯科のトレンド拡大など、いくつかの要因により大幅な成長を遂げています。さらに、発展途上地域における医療インフラ整備の取り組みも、歯科治療および関連製品の需要増加を牽引しています。さらに、再生バイオマテリアルの進歩も、市場の拡大に重要な役割を果たしています。
本レポートは、歯科軟組織再生市場を調査し、製品タイプ、用途、エンドユーザー、地域など、様々なセグメントにおける市場規模と将来の成長可能性を予測します。さらに、主要プレーヤーの企業概要、サービス内容、最近の動向、主要な市場戦略など、競合分析も掲載しています。
本レポートは、歯科軟組織再生市場における市場リーダーと新規参入企業の両方を支援するために作成されており、収益の詳細な推定値を提供します。これにより、関係者は競争環境を理解し、事業のポジショニングを改善し、効果的な市場開拓戦略を策定できるようになります。さらに、主要な推進要因、制約、課題、機会など、市場の最新動向に関する洞察も提供します。
主な推進要因（歯周病罹患率の上昇、審美歯科に対する意識の高まりと需要の増加、生体材料の進歩、再生技術の進歩）、制約要因（歯科サービスの不十分な償還と高額な費用、訓練を受けた歯科医師の不足）、機会（歯科診療所の統合とDSO活動の増加、新興経済国への注目の高まりと可処分所得水準の上昇、新興国における歯科観光の増加）、課題（主要な市場プレーヤーが直面する価格圧力、厳格な規制環境）の分析。
Report Description
The dental soft-tissue regeneration market is projected to grow from USD 0.38 billion in 2025 to USD 0.53 billion by 2030, at a CAGR of 6.8% during this period. This market has experienced significant growth due to several factors, including the rising incidence of periodontal diseases, increasing awareness of oral health, and the growing trend of cosmetic dentistry. Furthermore, initiatives to develop healthcare infrastructure in underdeveloped regions are driving the demand for more dental treatments and related products. Additionally, advancements in regenerative biomaterials have also played a crucial role in the market’s expansion.
“By product type, the collagen-based membranes segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.”
Based on product type, the collagen-based membranes segment is expected to dominate the dental soft-tissue regeneration market due to several factors. Collagen-based membranes act as barriers that guide tissue growth, supporting the healing of periodontal and implant-related defects. Additionally, these membranes can integrate with surrounding tissues and promote the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials are also contributing to the growth of this market.
“By application, the implantology segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.”
The implantology segment is expected to hold the largest share of the dental soft-tissue regeneration market due to factors such as the growing aging population, increased awareness of oral health, and rising demand for cosmetic dentistry. Products like collagen membranes, soft-tissue grafts, and advanced bioactive materials are increasingly utilized to promote healing in peri-implant soft tissues. Additionally, innovations in soft-tissue regenerative solutions and heightened awareness of dental aesthetics further contribute to the growth of the dental soft-tissue regeneration market.
“By region, North America accounted for the largest share of the dental soft-tissue regeneration market.”
Due to several factors, North America is expected to account for the largest share of the dental soft-tissue regeneration market during the forecast period. The region has advanced healthcare infrastructure and high healthcare expenditure rates, which drive the demand for sophisticated dental care treatments. Additionally, the significant increase in the geriatric population, who are more susceptible to periodontal diseases, accounts for a considerable portion of the treatments needed in North America.
Favorable government policies, reimbursement frameworks for dental care treatments, and high patient insurance coverage further encourage access to advanced dental care. Moreover, ongoing research and development in dental technologies and biomaterials support the expansion of this market in the region.
A breakdown of the primary participants (supply side) for the dental soft-tissue regeneration market referred to in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).
Research Coverage:
The report examines the dental soft-tissue regeneration market and seeks to estimate its market size and future growth potential across various segments, including product type, application, end user, and region. Additionally, the report features a competitive analysis of the key players in this market, including their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report is designed to assist both market leaders and new entrants in the dental soft-tissue regeneration market by providing close estimates of revenue figures. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and plan effective go-to-market strategies. Additionally, the report offers insights into the current trends in the market, including key drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries), and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
- Market Penetration: It contains comprehensive information on products offered by the key players in the global dental soft-tissue regeneration market. The report covers various segments, including product type, application, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental soft-tissue regeneration market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.
Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 24
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 26
1.4 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key sources for secondary research 28
2.1.1.2 Key data from secondary sources 29
2.1.2 PRIMARY DATA 29
2.1.2.1 Objectives of primary research 30
2.1.2.2 Key data from primary sources 30
2.1.2.3 Key industry insights 31
2.1.2.4 Breakdown of primaries 31
2.2 MARKET SIZE ESTIMATION 33
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 33
2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 34
2.2.3 TOP-DOWN APPROACH (SUPPLY-SIDE ANALYSIS) 36
2.3 DATA TRIANGULATION 39
2.4 MARKET SHARE ESTIMATION 40
2.5 STUDY ASSUMPTIONS 40
2.6 RESEARCH LIMITATIONS 41
2.7 RISK ANALYSIS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW 45
4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE AND COUNTRY (2024) 46
4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX 47
4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 47
4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Rising prevalence of periodontal diseases 50
5.2.1.2 Growing demand for cosmetic dentistry 50
5.2.1.3 Rising popularity of biodegradable biomaterials 51
5.2.1.4 Advancements in regenerative technologies 51
5.2.2 RESTRAINTS 52
5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services 52
5.2.2.2 Dearth of trained dental practitioners 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Introduction of dental service organizations and consolidation of dental practices 53
5.2.3.2 Growth opportunities in emerging economies 53
5.2.3.3 Increasing popularity of dental tourism in emerging countries 53
5.2.4 CHALLENGES 54
5.2.4.1 Pricing pressure and increased market competition 54
5.2.4.2 Stringent regulatory environment 54
5.3 INDUSTRY TRENDS 55
5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY 55
5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES 55
5.4 VALUE CHAIN ANALYSIS 55
5.5 TECHNOLOGY ANALYSIS 57
5.5.1 KEY TECHNOLOGIES 57
5.5.1.1 3D bioprinting 57
5.5.2 COMPLEMENTARY TECHNOLOGIES 58
5.5.2.1 Laser-assisted technology 58
5.5.3 ADJACENT TECHNOLOGIES 58
5.5.3.1 Advanced biomaterials 58
5.6 PORTER’S FIVE FORCES ANALYSIS 59
5.6.1 THREAT OF NEW ENTRANTS 60
5.6.2 THREAT OF SUBSTITUTES 60
5.6.3 BARGAINING POWER OF SUPPLIERS 60
5.6.4 BARGAINING POWER OF BUYERS 60
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.7 KEY STAKEHOLDERS & BUYING CRITERIA 61
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 61
5.7.2 KEY BUYING CRITERIA 62
5.8 REGULATORY ANALYSIS 62
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
5.8.2 REGULATORY FRAMEWORK 65
5.8.2.1 North America 65
5.8.2.1.1 US 65
5.8.2.2 Europe 66
5.8.2.3 Asia Pacific 67
5.8.2.3.1 India 67
5.8.2.3.2 China 67
5.8.2.3.3 Japan 67
5.9 PATENT ANALYSIS 67
5.9.1 KEY PATENTS GRANTED 69
5.10 TRADE ANALYSIS 70
5.10.1 IMPORT DATA FOR HS CODE 300640 70
5.10.2 EXPORT DATA FOR HS CODE 300640 71
5.11 PRICING ANALYSIS 71
5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022–2024 72
5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022–2024 73
5.12 KEY CONFERENCES & EVENTS, 2024–2025 73
5.13 UNMET NEEDS/END-USER EXPECTATIONS 75
5.14 ADJACENT MARKET ANALYSIS 76
5.15 ECOSYSTEM ANALYSIS 76
5.16 CASE STUDY ANALYSIS 78
5.16.1 GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND
IMPLANT WITH OSSIX PLUS 78
5.16.2 ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION 79
5.16.3 APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS 79
5.17 SUPPLY CHAIN ANALYSIS 80
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.19 INVESTMENT & FUNDING SCENARIO 82
5.20 REIMBURSEMENT SCENARIO ANALYSIS 82
5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET 83
5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2024 84
5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2024 84
5.24 IMPACT OF 2025 US TARIFF ON DENTAL SOFT-TISSUE REGENERATION MARKET 84
5.24.1 INTRODUCTION 84
5.24.2 KEY TARIFF RATES 85
5.24.3 PRICE IMPACT ANALYSIS 86
5.24.4 IMPACT ON COUNTRY/REGION 86
5.24.4.1 North America 86
5.24.4.1.1 US 86
5.24.4.2 Europe 87
5.24.4.3 Asia Pacific 87
5.24.5 IMPACT ON END-USE INDUSTRIES 87
6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE 88
6.1 INTRODUCTION 89
6.2 COLLAGEN-BASED MEMBRANES 89
6.2.1 POTENTIAL TO ENHANCE DENTAL TISSUE REGENERATION TO DRIVE MARKET 89
6.3 AUTOGRAFTS 90
6.3.1 HIGH COMPATIBILITY AND REDUCED INFECTION RISKS TO DRIVE MARKET 90
6.4 SYNTHETIC BIOMATERIALS 92
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN BIOMATERIALS TO FUEL MARKET GROWTH 92
6.5 OTHER PRODUCT TYPES 94
7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION 96
7.1 INTRODUCTION 97
7.2 IMPLANTOLOGY 97
7.2.1 GROWING NEED FOR IMPLANT-SUPPORTED SOFT-TISSUE REGENERATION TO DRIVE MARKET 97
7.3 PERIODONTOLOGY 98
7.3.1 INCREASING PREVALENCE OF PERIODONTAL DISEASES TO FAVOR MARKET GROWTH 98
7.4 OTHER APPLICATIONS 100
8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER 101
8.1 INTRODUCTION 102
8.2 DENTAL HOSPITALS 102
8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET 102
8.3 DSOS & INDEPENDENT CLINICS 104
8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND 104
8.4 ACADEMIC & RESEARCH INSTITUTES 106
8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH 106
9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION 108
9.1 INTRODUCTION 109
9.2 NORTH AMERICA 110
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 110
9.2.2 US 113
9.2.2.1 US to dominate North American dental soft-tissue regeneration market 113
9.2.3 CANADA 115
9.2.3.1 Stringent regulatory compliance to support market growth 115
9.3 EUROPE 116
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 117
9.3.2 GERMANY 119
9.3.2.1 Germany accounted for the largest share of European dental soft-tissue regeneration market in 2024 119
9.3.3 UK 121
9.3.3.1 Rising number of geriatric patients to drive market 121
9.3.4 FRANCE 123
9.3.4.1 Well-established healthcare system to drive market 123
9.3.5 SPAIN 124
9.3.5.1 Favorable government initiatives for providing dental coverage to support market growth 124
9.3.6 ITALY 126
9.3.6.1 Increasing penetration of dental products to drive market growth 126
9.3.7 REST OF EUROPE 128
9.4 ASIA PACIFIC 129
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 129
9.4.2 JAPAN 132
9.4.2.1 Rising geriatric population to support market growth 132
9.4.3 CHINA 134
9.4.3.1 Growing geriatric population and increasing per capita income to support market growth 134
9.4.4 INDIA 135
9.4.4.1 Growing dental care sector to fuel market growth 135
9.4.5 AUSTRALIA 137
9.4.5.1 Growing healthcare expenditure to aid market growth 137
9.4.6 SOUTH KOREA 139
9.4.6.1 Well-developed healthcare sector to drive market 139
9.4.7 REST OF ASIA PACIFIC 140
9.5 LATIN AMERICA 142
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 142
9.5.2 BRAZIL 144
9.5.2.1 Brazil to hold largest share in Latin American market 144
9.5.3 MEXICO 145
9.5.3.1 Increasing healthcare infrastructure to propel market growth 145
9.5.4 ARGENTINA 147
9.5.4.1 Advancements in dental technology to spur growth 147
9.5.5 REST OF LATIN AMERICA 149
9.6 MIDDLE EAST & AFRICA 150
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH 150
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 150
9.7 GCC COUNTRIES 152
9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH 152
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 152
10 COMPETITIVE LANDSCAPE 154
10.1 INTRODUCTION 154
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 154
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET 155
10.3 REVENUE ANALYSIS, 2019–2023 156
10.4 MARKET SHARE ANALYSIS, 2024 156
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 159
10.5.1 STARS 159
10.5.2 EMERGING LEADERS 159
10.5.3 PERVASIVE PLAYERS 159
10.5.4 PARTICIPANTS 159
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 161
10.5.5.1 Company footprint 161
10.5.5.2 Region footprint 162
10.5.5.3 Product footprint 163
10.5.5.4 Application footprint 164
10.5.5.5 End-user footprint 165
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 166
10.6.1 PROGRESSIVE COMPANIES 166
10.6.2 RESPONSIVE COMPANIES 166
10.6.3 DYNAMIC COMPANIES 166
10.6.4 STARTING BLOCKS 166
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 168
10.6.5.1 Detailed list of key startups/SMEs 168
10.6.5.2 Competitive benchmarking of startups/SMEs, by product type 169
10.6.5.3 Competitive benchmarking of startups/SMEs, by region 169
10.7 BRAND/PRODUCT COMPARISON 170
10.8 R&D EXPENDITURE OF KEY PLAYERS 171
10.9 COMPANY VALUATION & FINANCIAL METRICS 171
10.9.1 FINANCIAL METRICS 171
10.9.2 COMPANY VALUATION 172
10.10 COMPETITIVE SCENARIO 172
10.10.1 PRODUCT LAUNCHES 172
10.10.2 DEALS 173
10.10.3 EXPANSIONS 174
11 COMPANY PROFILES 175
11.1 KEY PLAYERS 175
11.1.1 GEISTLICH PHARMA AG 175
11.1.1.1 Business overview 175
11.1.1.2 Products offered 175
11.1.1.3 Recent developments 176
11.1.1.3.1 Deals 176
11.1.1.3.2 Expansions 176
11.1.1.4 MnM view 176
11.1.1.4.1 Right to win 176
11.1.1.4.2 Strategic choices 176
11.1.1.4.3 Weaknesses & competitive threats 176
11.1.2 INSTITUT STRAUMANN AG 177
11.1.2.1 Business overview 177
11.1.2.2 Products offered 178
11.1.2.3 MnM view 179
11.1.2.3.1 Right to win 179
11.1.2.3.2 Strategic choices 179
11.1.2.3.3 Weaknesses & competitive threats 179
11.1.3 HENRY SCHEIN, INC. 180
11.1.3.1 Business overview 180
11.1.3.2 Products offered 181
11.1.3.3 Recent developments 182
11.1.3.3.1 Deals 182
11.1.3.4 MnM view 183
11.1.3.4.1 Right to win 183
11.1.3.4.2 Strategic choices 183
11.1.3.4.3 Weaknesses & competitive threats 183
11.1.4 ENVISTA 184
11.1.4.1 Business overview 184
11.1.4.2 Products offered 186
11.1.4.3 Recent developments 186
11.1.4.3.1 Deals 186
11.1.4.4 MnM view 187
11.1.4.4.1 Right to win 187
11.1.4.4.2 Strategic choices 187
11.1.4.4.3 Weaknesses & competitive threats 187
11.1.5 ZIMVIE INC. 188
11.1.5.1 Business overview 188
11.1.5.2 Products offered 189
11.1.5.3 Recent developments 190
11.1.5.3.1 Deals 190
11.1.5.4 MnM view 190
11.1.5.4.1 Right to win 190
11.1.5.4.2 Strategic choices 190
11.1.5.4.3 Weaknesses & competitive threats 190
11.1.6 DENTSPLY SIRONA INC. 191
11.1.6.1 Business overview 191
11.1.6.2 Products offered 192
11.1.6.3 Recent developments 193
11.1.6.3.1 Product launches 193
11.1.6.3.2 Deals 193
11.1.7 ABBVIE INC. 194
11.1.7.1 Business overview 194
11.1.7.2 Products offered 195
11.1.7.3 Recent developments 196
11.1.7.3.1 Expansions 196
11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC 197
11.1.8.1 Business overview 197
11.1.8.2 Products offered 198
11.1.8.3 Recent developments 199
11.1.8.3.1 Deals 199
11.1.9 TISSUE REGENIX 200
11.1.9.1 Business overview 200
11.1.9.2 Products offered 201
11.1.10 SEPTODONT HOLDING 202
11.1.10.1 Business overview 202
11.1.10.2 Products offered 202
11.1.10.3 Recent developments 202
11.1.10.3.1 Deals 202
11.1.11 MEDICAL CONSULT IMPLANTS GMBH 203
11.1.11.1 Business overview 203
11.1.11.2 Products offered 203
11.1.12 MECCELLIS BIOTECH 204
11.1.12.1 Business overview 204
11.1.12.2 Products offered 204
11.1.13 REGEDENT AG 205
11.1.13.1 Business overview 205
11.1.13.2 Products offered 205
11.1.14 REGENITY 206
11.1.14.1 Business overview 206
11.1.14.2 Products offered 206
11.1.14.3 Recent developments 207
11.1.14.3.1 Deals 207
11.1.15 AD SURGICAL 208
11.1.15.1 Business overview 208
11.1.15.2 Products offered 208
11.2 OTHER PLAYERS 209
11.2.1 LIFENET HEALTH 209
11.2.2 B. & B. DENTAL S.R.L. 210
11.2.3 ALPHA-BIO TEC. LTD. 211
11.2.4 LASAK S.R.O. 212
11.2.5 KEYSTONE DENTAL GROUP 213
11.2.6 NEOSS AG 214
11.2.7 BEGO GMBH & CO. KG 215
11.2.8 BIOTECH DENTAL 216
11.2.9 SAMYANG HOLDINGS CORPORATION 217
11.2.10 RTI SURGICAL 218
12 APPENDIX 219
12.1 DISCUSSION GUIDE 219
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 223
12.3 CUSTOMIZATION OPTIONS 225
12.4 RELATED REPORTS 225
12.5 AUTHOR DETAILS 226
LIST OF TABLES
TABLE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: INCLUSIONS & EXCLUSIONS 25
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD), 2019–2023 26
TABLE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RISK ANALYSIS 41
TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY, 2021 VS. 2022 51
TABLE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES 59
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR TOP THREE APPLICATIONS 61
TABLE 7 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 65
TABLE 13 DENTAL SOFT-TISSUE REGENERATION MARKET: INNOVATIONS AND
PATENT REGISTRATIONS, 2022−2024 69
TABLE 14 IMPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 70
TABLE 15 EXPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 71
TABLE 16 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 72
TABLE 17 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022–2024 (USD) 73
TABLE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025 74
TABLE 19 DENTAL SOFT-TISSUE REGENERATION MARKET: UNMET NEEDS/END-USER EXPECTATIONS 75
TABLE 20 DENTAL SOFT-TISSUE REGENERATION MARKET: ROLE IN ECOSYSTEM 77
TABLE 21 CASE STUDY 1: GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH
AND IMPLANT WITH OSSIX PLUS 78
TABLE 22 CASE STUDY 2: ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION 79
TABLE 23 CASE STUDY 3: APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS 79
TABLE 24 PREVALENCE OF GINGIVAL DISEASES BY KEY REGION 2024 84
TABLE 25 TOTAL NUMBER OF SURGERIES BY KEY REGION 2024 84
TABLE 26 US ADJUSTED RECIPROCAL TARIFF RATES 85
TABLE 27 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DENTAL SOFT-TISSUE REGENERATION 86
TABLE 28 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 89
TABLE 29 DENTAL SOFT-TISSUE REGENERATION MARKET FOR COLLAGEN-BASED MEMBRANES, BY COUNTRY, 2023–2030 (USD MILLION) 90
TABLE 30 DENTAL SOFT-TISSUE REGENERATION MARKET FOR AUTOGRAFTS,
BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 31 DENTAL SOFT-TISSUE REGENERATION MARKET FOR SYNTHETIC BIOMATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 32 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER PRODUCT TYPES,
BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 33 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 97
TABLE 34 DENTAL SOFT-TISSUE REGENERATION MARKET FOR IMPLANTOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 35 DENTAL SOFT-TISSUE REGENERATION MARKET FOR PERIODONTOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 36 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 37 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2023–2030 (USD MILLION) 102
TABLE 38 DENTAL SOFT-TISSUE REGENERATION MARKET FOR DENTAL HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 39 DENTAL SOFT-TISSUE REGENERATION FOR DSOS & INDEPENDENT CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 40 DENTAL SOFT-TISSUE REGENERATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 41 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 42 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 43 NORTH AMERICA, DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 112
TABLE 44 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 112
TABLE 45 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 112
TABLE 46 US: KEY MACROINDICATORS 113
TABLE 47 US: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 114
TABLE 48 US: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 114
TABLE 49 US: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 114
TABLE 50 CANADA: KEY MACROINDICATORS 115
TABLE 51 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 115
TABLE 52 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 116
TABLE 53 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 116
TABLE 54 EUROPE DENTAL SOFT-TISSUE REGENERATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 55 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 118
TABLE 56 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 118
TABLE 57 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 119
TABLE 58 GERMANY: KEY MACROINDICATORS 120
TABLE 59 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 120
TABLE 60 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 120
TABLE 61 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 121
TABLE 62 UK: KEY MACROINDICATORS 121
TABLE 63 UK: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 122
TABLE 64 UK: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 122
TABLE 65 UK: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 122
TABLE 66 FRANCE: KEY MACROINDICATORS 123
TABLE 67 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 123
TABLE 68 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 124
TABLE 69 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 124
TABLE 70 SPAIN: KEY MACROINDICATORS 125
TABLE 71 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 125
TABLE 72 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 73 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 126
TABLE 74 ITALY: KEY MACROINDICATORS 126
TABLE 75 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 127
TABLE 76 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 127
TABLE 77 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 127
TABLE 78 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128
TABLE 79 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 128
TABLE 80 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 129
TABLE 81 ASIA PACIFIC DENTAL SOFT-TISSUE REGENERATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 82 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 131
TABLE 83 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 131
TABLE 84 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 132
TABLE 85 JAPAN: KEY MACROINDICATORS 132
TABLE 86 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 133
TABLE 87 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 133
TABLE 88 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 133
TABLE 89 CHINA: KEY MACROINDICATORS 134
TABLE 90 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134
TABLE 91 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 135
TABLE 92 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 135
TABLE 93 INDIA: KEY MACROINDICATORS 136
TABLE 94 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 136
TABLE 95 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 136
TABLE 96 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 137
TABLE 97 AUSTRALIA: KEY MACROINDICATORS 137
TABLE 98 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 138
TABLE 99 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 138
TABLE 100 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 138
TABLE 101 SOUTH KOREA: KEY MACROINDICATORS 139
TABLE 102 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139
TABLE 103 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 140
TABLE 104 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 140
TABLE 105 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 141
TABLE 106 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 141
TABLE 107 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 141
TABLE 108 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 109 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 143
TABLE 110 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 143
TABLE 111 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 143
TABLE 112 BRAZIL: KEY MACROINDICATORS 144
TABLE 113 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 144
TABLE 114 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 145
TABLE 115 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 145
TABLE 116 MEXICO: KEY MACROINDICATORS 146
TABLE 117 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 146
TABLE 118 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 146
TABLE 119 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 147
TABLE 120 ARGENTINA: KEY MACROINDICATORS 147
TABLE 121 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 148
TABLE 122 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 148
TABLE 123 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 148
TABLE 124 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 149
TABLE 125 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 149
TABLE 126 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 150
TABLE 127 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 151
TABLE 128 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 151
TABLE 129 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 151
TABLE 130 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 152
TABLE 131 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 153
TABLE 132 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 153
TABLE 133 DENTAL SOFT-TISSUE REGENERATION MARKET: DEGREE OF COMPETITION 157
TABLE 134 DENTAL SOFT-TISSUE REGENERATION MARKET: REGION FOOTPRINT 162
TABLE 135 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT FOOTPRINT 163
TABLE 136 DENTAL SOFT-TISSUE REGENERATION MARKET: APPLICATION FOOTPRINT 164
TABLE 137 DENTAL SOFT-TISSUE REGENERATION MARKET: END-USER FOOTPRINT 165
TABLE 138 DENTAL SOFT-TISSUE REGENERATION MARKET: DETAILED LIST OF
KEY STARTUPS/SMES 168
TABLE 139 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING
OF STARTUPS/SMES, BY PRODUCT TYPE 169
TABLE 140 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING
OF STARTUPS/SMES, BY REGION 169
TABLE 141 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT LAUNCHES,
JANUARY 2021–MARCH 2025 172
TABLE 142 DENTAL SOFT-TISSUE REGENERATION MARKET: DEALS,
JANUARY 2021–MARCH 2025 173
TABLE 143 DENTAL SOFT-TISSUE REGENERATION MARKET: EXPANSIONS,
JANUARY 2021–MARCH 2025 174
TABLE 144 GEISTLICH PHARMA AG: COMPANY OVERVIEW 175
TABLE 145 GEISTLICH PHARMA AG: PRODUCTS OFFERED 175
TABLE 146 GEISTLICH PHARMA AG: DEALS, JANUARY 2021–MARCH 2025 176
TABLE 147 GEISTLICH PHARMA AG: EXPANSIONS, JANUARY 2021–MARCH 2025 176
TABLE 148 INSTITUT STRAUMANN AG: COMPANY OVERVIEW 177
TABLE 149 INSTITUT STRAUMANN AG: PRODUCTS OFFERED 178
TABLE 150 HENRY SCHEIN, INC.: COMPANY OVERVIEW 180
TABLE 151 HENRY SCHEIN, INC.: PRODUCTS OFFERED 181
TABLE 152 HENRY SCHEIN, INC.: DEALS, JANUARY 2021–MARCH 2025 182
TABLE 153 ENVISTA: COMPANY OVERVIEW 184
TABLE 154 ENVISTA: PRODUCTS OFFERED 186
TABLE 155 ENVISTA: DEALS, JANUARY 2021–MARCH 2025 186
TABLE 156 ZIMVIE INC.: COMPANY OVERVIEW 188
TABLE 157 ZIMVIE INC.: PRODUCTS OFFERED 189
TABLE 158 ZIMVIE INC.: DEALS, JANUARY 2021–MARCH 2025 190
TABLE 159 DENTSPLY SIRONA INC.: COMPANY OVERVIEW 191
TABLE 160 DENTSPLY SIRONA INC.: PRODUCTS OFFERED 192
TABLE 161 DENTSPLY SIRONA INC.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 193
TABLE 162 DENTSPLY SIRONA INC.: DEALS, JANUARY 2021–MARCH 2025 193
TABLE 163 ABBVIE INC.: COMPANY OVERVIEW 194
TABLE 164 ABBVIE INC.: PRODUCTS OFFERED 195
TABLE 165 ABBVIE INC.: EXPANSIONS, JANUARY 2021–MARCH 2025 196
TABLE 166 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW 197
TABLE 167 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED 198
TABLE 168 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS,
JANUARY 2021–MARCH 2025 199
TABLE 169 TISSUE REGENIX: COMPANY OVERVIEW 200
TABLE 170 TISSUE REGENIX: PRODUCTS OFFERED 201
TABLE 171 SEPTODONT HOLDING: COMPANY OVERVIEW 202
TABLE 172 SEPTODONT HOLDING: PRODUCTS OFFERED 202
TABLE 173 SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025 202
TABLE 174 MEDICAL CONSULT IMPLANTS GMBH: COMPANY OVERVIEW 203
TABLE 175 MEDICAL CONSULT IMPLANTS GMBH: PRODUCTS OFFERED 203
TABLE 176 MECCELLIS BIOTECH: COMPANY OVERVIEW 204
TABLE 177 MECCELLIS BIOTECH: PRODUCTS OFFERED 204
TABLE 178 REGEDENT AG: COMPANY OVERVIEW 205
TABLE 179 REGEDENT AG: PRODUCTS OFFERED 205
TABLE 180 REGENITY: COMPANY OVERVIEW 206
TABLE 181 REGENITY: PRODUCTS OFFERED 206
TABLE 182 REGENITY: DEALS, JANUARY 2021–MARCH 2025 207
TABLE 183 AD SURGICAL: COMPANY OVERVIEW 208
TABLE 184 AD SURGICAL: PRODUCTS OFFERED 208
TABLE 185 LIFENET HEALTH: COMPANY OVERVIEW 209
TABLE 186 B. & B. DENTAL S.R.L.: COMPANY OVERVIEW 210
TABLE 187 ALPHA-BIO TEC. LTD.: COMPANY OVERVIEW 211
TABLE 188 LASAK S.R.O.: COMPANY OVERVIEW 212
TABLE 189 KEYSTONE DENTAL GROUP: COMPANY OVERVIEW 213
TABLE 190 NEOSS AG: COMPANY OVERVIEW 214
TABLE 191 BEGO GMBH & CO. KG: COMPANY OVERVIEW 215
TABLE 192 BIOTECH DENTAL: COMPANY OVERVIEW 216
TABLE 193 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW 217
TABLE 194 RTI SURGICAL: COMPANY OVERVIEW 218
LIST OF FIGURES
FIGURE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: SEGMENTS CONSIDERED
& GEOGRAPHICAL SPREAD 24
FIGURE 2 DENTAL SOFT-TISSUE REGENERATION MARKET: YEARS CONSIDERED 25
FIGURE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RESEARCH DESIGN 27
FIGURE 4 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM
SECONDARY SOURCES 29
FIGURE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY PRIMARY SOURCES 29
FIGURE 6 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM
PRIMARY SOURCES 30
FIGURE 7 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY INDUSTRY INSIGHTS 31
FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 32
FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 32
FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 33
FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION FOR INSTITUT STRAUMANN AG (2024) 34
FIGURE 13 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL SOFT-TISSUE REGENERATION MARKET (2023) 35
FIGURE 14 DENTAL SOFT-TISSUE REGENERATION MARKET: TOP-DOWN APPROACH 36
FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 37
FIGURE 16 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 17 DENTAL SOFT-TISSUE REGENERATION MARKET: DATA TRIANGULATION 39
FIGURE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: STUDY ASSUMPTIONS 40
FIGURE 19 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2025 VS. 2030 (USD MILLION) 42
FIGURE 20 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 43
FIGURE 21 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 43
FIGURE 22 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL SNAPSHOT 44
FIGURE 23 RISING PREVALENCE OF PERIODONTAL DISEASES AND GROWING FOCUS ON DENTAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET 45
FIGURE 24 REST OF ASIA PACIFIC AND COLLAGEN-BASED MEMBRANES COMMANDED LARGEST MARKET SHARE IN 2024 46
FIGURE 25 ASIA PACIFIC TO DOMINATE MARKET FROM 2025 TO 2030 47
FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 47
FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING
FORECAST PERIOD 48
FIGURE 28 DENTAL SOFT-TISSUE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 29 DENTAL SOFT-TISSUE REGENERATION MARKET: VALUE CHAIN ANALYSIS 56
FIGURE 30 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE APPLICATIONS 61
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62
FIGURE 33 NUMBER OF PATENT PUBLISHED (JANUARY 2014–NOVEMBER 2024) 68
FIGURE 34 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL SOFT-TISSUE REGENERATION (JANUARY 2014– NOVEMBER 2024) 68
FIGURE 35 TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014−NOVEMBER 2024 69
FIGURE 36 DENTAL SOFT-TISSUE REGENERATION MARKET: ADJACENT MARKETS 76
FIGURE 37 DENTAL SOFT-TISSUE REGENERATION MARKET: ECOSYSTEM ANALYSIS 77
FIGURE 38 DENTAL SOFT-TISSUE REGENERATION MARKET: SUPPLY CHAIN ANALYSIS 80
FIGURE 39 DENTAL SOFT-TISSUE REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
FIGURE 40 DENTAL SOFT-TISSUE REGENERATION MARKET: FUNDING AND
NUMBER OF DEALS, 2020–2023 82
FIGURE 41 DENTAL SOFT-TISSUE REGENERATION MARKET: IMPACT OF AI/GEN AI 83
FIGURE 42 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT 109
FIGURE 43 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 111
FIGURE 44 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 117
FIGURE 45 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 130
FIGURE 46 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET 155
FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2019–2023) 156
FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2024) 157
FIGURE 49 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 160
FIGURE 50 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY FOOTPRINT 161
FIGURE 51 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2024 167
FIGURE 52 DENTAL SOFT-TISSUE REGENERATION MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 170
FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023 171
FIGURE 54 EV/EBITDA OF KEY VENDORS 171
FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 172
FIGURE 56 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT 178
FIGURE 57 HENRY SCHEIN, INC.: COMPANY SNAPSHOT 181
FIGURE 58 ENVISTA: COMPANY SNAPSHOT 185
FIGURE 59 ZIMVIE INC.: COMPANY SNAPSHOT 189
FIGURE 60 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT 192
FIGURE 61 ABBVIE INC.: COMPANY SNAPSHOT 195
FIGURE 62 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT 198
FIGURE 63 TISSUE REGENIX: COMPANY SNAPSHOT 201
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11